loadpatents
name:-0.013682126998901
name:-0.0047838687896729
name:-0.00052690505981445
Jensen; Simon Bjerregaard Patent Filings

Jensen; Simon Bjerregaard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jensen; Simon Bjerregaard.The latest application filed is for "solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl) amino) caprylic acid".

Company Profile
0.6.9
  • Jensen; Simon Bjerregaard - Hilleroed DK
  • Jensen; Simon Bjerregaard - Hillerod N/A DK
  • Jensen; Simon Bjerregaard - Frederiksberg DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tablet formulation comprising a GLP-1 peptide and a delivery agent
Grant 11,033,499 - Jensen , et al. June 15, 2
2021-06-15
Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-hydroxybenzoyl) Amino) Caprylic Acid
App 20180360918 - Sauerberg; Per ;   et al.
2018-12-20
Tablet Formulation Comprising Semaglutide And A Delivery Agent
App 20180235888 - Jensen; Simon Bjerregaard ;   et al.
2018-08-23
Tablet formulation comprising semaglutide and a delivery agent
Grant 9,993,430 - Jensen , et al. June 12, 2
2018-06-12
Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
Grant 9,387,176 - Havelund , et al. July 12, 2
2016-07-12
Tablet Formulation Comprising A Peptide And A Delivery Agent
App 20150150811 - Jensen; Simon Bjerregaard ;   et al.
2015-06-04
Stable formulation of modified GLP-1
Grant 8,846,618 - Flink , et al. September 30, 2
2014-09-30
Stable Formulation Of Modified Glp-1
App 20100234299 - FLINK; JAMES M. ;   et al.
2010-09-16
Stable Formulation of Modified GLP-1
App 20090111752 - Flink; James M. ;   et al.
2009-04-30
Stable formulation of modified GLP-1
App 20080167226 - Flink; James M. ;   et al.
2008-07-10
Long-acting molecules in sustained release formulations
App 20060257479 - Jensen; Simon Bjerregaard ;   et al.
2006-11-16
Therapeutic use of factor XI
App 20050181978 - Rojkjaer, Rasmus ;   et al.
2005-08-18
Stable formulation of modified GLP-1
App 20030119734 - Flink, James M. ;   et al.
2003-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed